Avidity Partners Management LP lifted its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,500,328 shares of the company’s stock after buying an additional 718,478 shares during the quarter. Fusion Pharmaceuticals […]
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca smdailyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smdailyjournal.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
PORTLAND, Ore., May 29, 2024 /PRNewswire/ Allied Market Research published a report, titled, "Radiopharmaceuticals Market by End User (Hospitals and Clinics, Medical Imaging Centers, and
Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report) and Aura Biosciences (NASDAQ:AURA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Risk & Volatility Fusion Pharmaceuticals has a […]